搜索页_+moderate+to+severe+psoriasis

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

外文资源

SpringerLink电子期刊(165)

NATURE电子期刊(1)

Elsevier电子期刊(669)

在“Elsevier电子期刊”中，命中：669条，耗时：0.0319881 秒

在所有数据库中总计命中：853条

1.Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

作者：Andrew Blauvelt ; MD ; MBA^a ; ^{ablauvelt@oregonmedicalresearch.com} ; Kristian Reich ; MD^b ; Tsen-Fang Tsai ; MD^c ; Stephen Tyring ; MD ; PhD^d ; Francisco Vanaclocha ; MD^e ; Kü ; lli Kingo ; MD ; PhD^f ; Michael Ziv ; MD ; BSc^g ; Andreas Pinter ; MD^h ; Ronald Vender ; MD ; FRCPCⁱ ; Sophie Hugot ; MSc^j ; Ruquan You ; MSc^k ; Marina Milutinovic ; MD^j ; Diamant Thaçi ; MD^l

关键词：psoriasis ; secukinumab ; ustekinumab ; clinical trial ; Psoriasis Area and Severity Index (PASI) ; efficacy ; safety

刊名：Journal of the American Academy of Dermatology

出版年：2017

2.An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

作者：Richard B Warren ; MD^a ; Prof Ulrich Mrowietz ; MD^b ; Ralph von Kiedrowski ; MD^c ; Johannes Niesmann ; MD^d ; Dagmar Wilsmann-Theis ; MD^e ; Kamran Ghoreschi ; MD^f ; Ina Zschocke ; PhD^g ; Thomas M Falk ; PhD^h ; Norbert Blö ; dorn-Schlicht ; MD^h ; Prof Kristian Reich ; MD^g ; ^h ; ^{kreich@dermatologikum.de}

刊名：The Lancet

出版年：2017

3.Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model

作者：Wenjuan Chen^a ; ¹ ; Yu Gong^a ; ¹ ; Xilin Zhang^b ; ¹ ; Yunlei Tong^a ; Xiuxiu Wang^c ; Chengwen Fei^a ; Hui Xu^a ; Qian Yu^a ; Yao Wang^a ; Yuling Shi^a ; ^{shiyuling1973@tongji.edu.cn}

关键词：Psoriasis ; IL-27 ; Th17 ; Imiquimod

刊名：Journal of Dermatological Science

出版年：2017

4.Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry

作者：S. Galiano Mejí ; as^a ; ^{yayogaliano@hotmail.com} ; G. Carretero^b ; C. Ferrandiz^c ; F. Vanaclocha^d ; E. Daudé ; n^e ; F.J. Gó ; mez-Garcí ; a^f ; E. Herrera-Ceballos^g ; I. Belinchó ; n-Romero^h ; J.L. Sá ; nchez-Carazoⁱ ; J.L. Ló ; pez-Estebaranz^j ; M. Alsina^k ; M. Ferrá ; n^l ; R. Torrado^b ; J.M. Carrascosa^c ; R. Rivera^d ; M. Llamas-Velasco^e ; R. Jimé ; nez-Puya^f ; Mª ; V. Mendiola^g ; D. Ruiz-Genao^j ; M.A. Descalzo^m ; P. de la Cueva Dobao^a ; del grupo Biobadaderm

关键词：Psoriasis ; Biologic agents ; Systemic therapy ; Surgery ; Treatment interruption

刊名：Actas Dermo-Sifiliográficas (English Edition)

出版年：2017

5.Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

作者：Paula Dá ; vila-Seijo¹ ; ¹⁵ ; ^{pauladavilaseijo@gmail.com} ; Esteban Dauden² ; M.A. Descalzo¹ ; Gregorio Carretero³ ; José ; -Manuel Carrascosa⁴ ; Francisco Vanaclocha⁵ ; Francisco-José ; Gó ; mez-Garcí ; a⁶ ; Pablo De la Cueva-Dobao⁷ ; Enrique Herrera-Ceballos⁸ ; Isabel Belinchó ; n⁹ ; José ; -Luis Ló ; pez-Estebaranz¹⁰ ; Merce Alsina¹¹ ; José ; -Luis Sá ; nchez-Carazo¹² ; Marta Ferrá ; n¹³ ; Rosa Torrado³ ; Carlos Ferrandiz⁴ ; Raquel Rivera⁵ ; Mar Llamas² ; Rafael Jimé ; nez-Puya⁶ ; Ignacio Garcí ; a-Doval¹ ; ¹⁴ ; the BIOBADADERM Study GroupBeatriz Pé ; rez Zafrilla ; Carlos Muñ ; oz-Santos ; Victoria Mendiola-Ferná ; ndez ; Cristina Sá ; nchez Roldán ; Diana Ruiz-Genao ; Begoñ ; a Echeverría ; Sagrario Galiano Mejí ; as

关键词：BIOBADADERM ; Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases ; CI ; confidence interval ; PASI ; Psoriasis Area Severity Index ; RR ; risk ratio ; TNF ; tumor necrosis factor

刊名：Journal of Investigative Dermatology

出版年：2017

6.Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis

作者：Robert Bissonnette ; MD^a ; ^{rbissonnette@innovaderm.ca" class="auth_mail" title="E-mail the corresponding author} ; David M. Pariser ; MD^b ; Norman R. Wasel ; MD ; FRCPC^c ; Joana Goncalves ; MD^d ; Robert M. Day ; PhD^d ; Rongdean Chen ; PhD^d ; Michael Sebastian ; MD^e

关键词：apremilast ; difficult to treat ; ESTEEM ; moderate to severe ; palmoplantar psoriasis ; palms ; PSOR-005 ; soles

刊名：Journal of the American Academy of Dermatology

出版年：2016

7.Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary

作者：Steven R. Feldman^a ; Susan D. Mathias^b ; Brad Schenkel^c ; Hilary H. Colwell^b ; Kelly McQuarrie^d ; Bruce Randazzo^d ; Chenglong Han^d ; ^{CHan3@its.jnj.com" class="auth_mail" title="E-mail the corresponding author}

关键词：BSA ; Body Surface Area ; DLQI ; Dermatology Life Quality Index ; FDA ; Food and Drug Administration ; HRQoL ; Health-Related Quality of Life ; IRB ; Institutional Review Board ; PASI ; Psoriasis Area and Severity Index ; PGA ; Physician Global Assessment ; PRO ; Patient-Reported Outcomes ; PsO ; Psoriasis ; PSSD ; Psoriasis Symptoms and Signs Diary ; US ; United States

刊名：Journal of Dermatology & Dermatologic Surgery

出版年：2016

8.Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis

作者：Peter C.M. van de Kerkhof ; MD ; PhD^a ; ^{peter.vandeKerkhof@radboudumc.nl" class="auth_mail" title="E-mail the corresponding author} ; Christopher E.M. Griffiths ; MD^b ; Kristian Reich ; MD ; PhD^c ; Craig L. Leonardi ; MD^d ; Andrew Blauvelt ; MD ; MBA^e ; Tsen-Fang Tsai ; MD^f ; Yankun Gong ; PhD^g ; Jiaqing Huang ; MD ; PhD^h ; Charis Papavassilis ; MD ; PhDⁱ ; Todd Fox ; RPh ; PharmB ; ACPRⁱ

关键词：long-term safety ; phase II studies ; phase III studies ; pooled analysis ; psoriasis ; secukinumab

刊名：Journal of the American Academy of Dermatology

出版年：2016

9.The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis

作者：Paolo Dapavo ; MD^a ; Igor Vujic ; MD^b ; ^c ; Maria Teresa Fierro ; MD^a ; Pietro Quaglino ; MD^a ; Martina Sanlorenzo ; MD^a ; ^{martina.sanlorenzo@hotmail.it" class="auth_mail" title="E-mail the corresponding author}

关键词：biosimilar ; CT-P13 ; infliximab ; psoriasis ; Remicade ; Remsima

刊名：Journal of the American Academy of Dermatology

出版年：2016

10.Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis

作者：Steven R. Feldman ; MD ; PhD^a ; Diamant Thaçi ; MD ; PhD^b ; Melinda Gooderham ; MD ; MSc^c ; Matthias Augustin ; MD^d ; Claudia de la Cruz ; MD^e ; Lotus Mallbris ; MD ; PhD^f ; ^&lowast ; ; Marjorie Buonanno ; MSN^g ; Svitlana Tatulych ; MD^g ; Mandeep Kaur ; MD ; MS^f ; Shuping Lan ; MS ; MPH^g ; Hernan Valdez ; MD^h ; Carla Mamolo ; PhD^g ; ^{carla.m.mamolo@pfizer.com" class="auth_mail" title="E-mail the corresponding author}

刊名：Journal of the American Academy of Dermatology

出版年：2016

按检索点细分(669)

题名(473)

关键词(5)

文摘(264)

按出版年细分(669)

2027年及以后(49)

2017年(5)

2016年(91)

2015年(6)

2013年(68)

2012年(68)

2011年(76)

2010年(52)

2009年(52)

2008年(45)

2007年(51)

2006年(8)

2005年(30)

2004年(23)

2003年(9)

2002年(3)

2001年(6)

2000年(7)

2000年及以前(20)